{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:11:37Z","timestamp":1762607497847},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Equine Veterinary Science"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jevs.2019.02.004","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T23:12:34Z","timestamp":1550877154000},"page":"17-22","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Presumed Sulfonamide-Associated Uveitis With Stevens-Johnson Syndrome in a Quarter Horse Mare"],"prefix":"10.1016","volume":"77","author":[{"given":"Eva","family":"Potocnik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Drozdzewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jevs.2019.02.004_bib1","series-title":"Equine formulary","first-page":"153","author":"Knottenbelt","year":"2015"},{"key":"10.1016\/j.jevs.2019.02.004_bib2","series-title":"Equine Internal Medicine","first-page":"236","author":"Reed","year":"2018"},{"key":"10.1016\/j.jevs.2019.02.004_bib3","series-title":"The equnie hospital manual","first-page":"365","author":"Corley","year":"2008"},{"key":"10.1016\/j.jevs.2019.02.004_bib4","doi-asserted-by":"crossref","first-page":"576","DOI":"10.2746\/0425164044864525","article-title":"Endoscopic scoring of mucus quantity and quality: observer and horse variance and relationship to inflammation, mucus viscoelasticity and volume","volume":"36","author":"Gerber","year":"2004","journal-title":"Equine Vet J"},{"key":"10.1016\/j.jevs.2019.02.004_bib5","series-title":"Equine emergency and critical care medicine","first-page":"731","author":"Southwood","year":"2015"},{"key":"10.1016\/j.jevs.2019.02.004_bib6","series-title":"Equine clinical pharmacology","author":"Bertone","year":"2004"},{"key":"10.1016\/j.jevs.2019.02.004_bib7","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/eve.12000","article-title":"Pancytopenia in two horses following administration of potentiated sulfonamide antimicrobials","volume":"27","author":"Cudmore","year":"2015","journal-title":"Equine Vet Educ"},{"key":"10.1016\/j.jevs.2019.02.004_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.2042-3306.2010.00158.x","article-title":"Supect novel adverse drug reactions to trimethoprimsulphonamide combinations in horses: a case series","volume":"43","author":"Stack","year":"2011","journal-title":"Equine Vet J"},{"key":"10.1016\/j.jevs.2019.02.004_bib9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2885.1994.tb00524.x","article-title":"Trimethoprim\/sulfonamide combinations in the horse: a review","volume":"17","author":"Van Duijkere","year":"1994","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.jevs.2019.02.004_bib10","first-page":"75","article-title":"Rational selection of antimicrobials for use in horses","volume":"47","author":"Wilson","year":"2001","journal-title":"AAEP Proceedings"},{"key":"10.1016\/j.jevs.2019.02.004_bib11","series-title":"Small animal clinical pharmacology & therapeutics","first-page":"247","author":"Boothe","year":"2012"},{"key":"10.1016\/j.jevs.2019.02.004_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2885.2004.00576.x","article-title":"Idiosyncratic toxicity associated with potentiated sulfonamides in the dog","volume":"27","author":"Trepanier","year":"2004","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.jevs.2019.02.004_bib13","series-title":"Ocular inflammatory disease and uveitis manual: diagnosis and treatment","author":"Huang","year":"2010"},{"key":"10.1016\/j.jevs.2019.02.004_bib14","series-title":"Entz\u00fcndliche Augenerkrankungen","first-page":"494","author":"Pleyer","year":"2014"},{"key":"10.1016\/j.jevs.2019.02.004_bib15","series-title":"Unerw\u00fcnschte Arzneimittelwirkungen in der Augenheilkunde","first-page":"92","author":"Schlote","year":"2011"},{"key":"10.1016\/j.jevs.2019.02.004_bib16","series-title":"Clinical ocular pharmacology","first-page":"226","author":"Bartlett","year":"1989"},{"key":"10.1016\/j.jevs.2019.02.004_bib17","series-title":"Medikament\u00f6se Augentherapie","first-page":"118","author":"Erb","year":"2000"},{"key":"10.1016\/j.jevs.2019.02.004_bib18","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson Syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jevs.2019.02.004_bib19","series-title":"Equine dermatology","first-page":"341","author":"Scott","year":"2011"},{"key":"10.1016\/j.jevs.2019.02.004_bib20","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0190-9622(96)90732-X","article-title":"Mycoplasma pneumonia infection is associated with Stevens-Johnson syndrome, not erythema multiforme (von Hebra)","volume":"35","author":"Tay","year":"1996","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jevs.2019.02.004_bib21","series-title":"Augenheilkunde, Dermatologie, HNO. In 5 Tagen","first-page":"152","author":"Goebeler","year":"2011"},{"key":"10.1016\/j.jevs.2019.02.004_bib22","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ccc.2007.12.011","article-title":"Antibiotic adverse reactions and drug interactions","volume":"24","author":"Granowitz","year":"2008","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.jevs.2019.02.004_bib23","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1096\/fasebj.13.13.1688","article-title":"Cytotoxity of sulfonamide reactive metabolites: apoptosis and selective toxicity of CD8+ cells by the hydroxylamine of sulfamethocazole","volume":"13","author":"Hess","year":"1999","journal-title":"FASEB J"},{"key":"10.1016\/j.jevs.2019.02.004_bib24","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1021\/tx034098h","article-title":"Do arylhydroxylamine metabolites mediate idiosyncratic reactions associated with sulfonamides?","volume":"16","author":"Svensson","year":"2003","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.jevs.2019.02.004_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0190-9622(08)81810-5","article-title":"Esophageal necrosis in the Stevens-Johnson syndrome","volume":"29","author":"Mah\u00e9","year":"1993","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jevs.2019.02.004_bib26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/j.1552-4604.1998.tb04454.x","article-title":"The effect of cimetidine on the formation of sulfamethoxazole hydroxylamine in patients with human immunodeficiency virus","volume":"38","author":"Lehmann","year":"1998","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jevs.2019.02.004_bib27","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jaci.2008.06.013","article-title":"Increased soluble Fas ligand levels in patients with Stevens-Johnson symdrome and toxic epidermal necrolysis preceding skin detachment","volume":"122","author":"Murata","year":"2008","journal-title":"J\u00a0Allergy Clinimmunol"},{"key":"10.1016\/j.jevs.2019.02.004_bib28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1128\/CDLI.2.2.199-204.1995","article-title":"Immune response to sulfamethoxyzole in patients with AIDS","volume":"2","author":"Daftarian","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jevs.2019.02.004_bib29","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0009-9236(96)80011-7","article-title":"Inhibition of sulfamethoxazole hydroxylamine formation by fluconazole in human liver microsomes and healthy volunteers","volume":"59","author":"Mitra","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jevs.2019.02.004_bib30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4103\/0253-7613.99346","article-title":"Trimethoprim-sulfamethoxazole-induced steven Johnson syndrome in an HIV-infected patient","volume":"44","author":"Tagi","year":"2012","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.jevs.2019.02.004_bib31","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1046\/j.1365-2222.1998.00419.x","article-title":"T-cell-mediated cytotoxity against keratinocytes in sulfamethoxazole-induced skin reactions","volume":"28","author":"Schnyder","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jevs.2019.02.004_bib32","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1586\/eci.11.66","article-title":"The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"7","author":"Mockenhaupt","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jevs.2019.02.004_bib33","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1046\/j.1439-0353.2004.04524.x","article-title":"Mechanisms of cutaneous drug reactions","volume":"2","author":"Yawalkar","year":"2004","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.jevs.2019.02.004_bib34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1440-0960.2011.00862.x","article-title":"The management of toxic epidermal necrolysis","volume":"53","author":"Fernando","year":"2012","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jevs.2019.02.004_bib35","first-page":"347","article-title":"The effect of fluconazole and ketoconazole on the metabolism of sulphamethoxazole","volume":"42","author":"Gill","year":"1996","journal-title":"Br J Clinpharmacol"},{"key":"10.1016\/j.jevs.2019.02.004_bib36","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1345\/aph.1E350","article-title":"Sulfonamide Cross-Reactivity: Fact of Fiction?","volume":"39","author":"Johnson","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jevs.2019.02.004_bib37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.2042-3306.2010.tb05640.x","article-title":"Ocular manifestations of systemic disease in horses","volume":"37","author":"Hughes","year":"2010","journal-title":"Equine Vet J Suppl"},{"key":"10.1016\/j.jevs.2019.02.004_bib38","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jevs.2019.02.004_bib39","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/0300985814537530","article-title":"Clinical and Microscopic Characteristics of Canine Toxic Epidermal Necrolysis","volume":"52","author":"Banovic","year":"2015","journal-title":"Vet Pathol"},{"key":"10.1016\/j.jevs.2019.02.004_bib40","first-page":"321","article-title":"Erythema multiforme in the horse: literature review and report of 9 cases (1988-1996)","volume":"20","author":"Scott","year":"1998","journal-title":"Equine Pract"},{"key":"10.1016\/j.jevs.2019.02.004_bib41","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.2042-3292.2007.tb00550.x","article-title":"The acute phase protein serum amyloid A (SAA) as a marker of inflammation in horses","volume":"19","author":"Jacobsen","year":"2007","journal-title":"Equine Vet Educ"},{"key":"10.1016\/j.jevs.2019.02.004_bib42","series-title":"Equine fluid therapy","first-page":"164","author":"Fielding","year":"2015"},{"key":"10.1016\/j.jevs.2019.02.004_bib43","series-title":"Equine ophtalmology","first-page":"401","author":"Gilger","year":"2017"}],"container-title":["Journal of Equine Veterinary Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0737080618307603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0737080618307603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T11:54:39Z","timestamp":1606564479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0737080618307603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":43,"alternative-id":["S0737080618307603"],"URL":"https:\/\/doi.org\/10.1016\/j.jevs.2019.02.004","relation":{},"ISSN":["0737-0806"],"issn-type":[{"value":"0737-0806","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Presumed Sulfonamide-Associated Uveitis With Stevens-Johnson Syndrome in a Quarter Horse Mare","name":"articletitle","label":"Article Title"},{"value":"Journal of Equine Veterinary Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jevs.2019.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}